You just read:

Mérieux Développement and Paladin Capital Group Co-lead $55.5 Million Series C Financing Into Inscripta, a Leading Company in the Field of Gene Editing, in Preparation for Platform Expansion and Commercial Launch

News provided by

Mérieux Développement and Paladin Capital Group

28 Feb, 2018, 14:00 GMT